| 摘要: |
| 口服溶液剂具有剂量分布均一、给药剂量易调整、患者服用方便的特点,近年来在国内药品研发领域受到更多关注。为促进国内仿制药发展,明确化学药品仿制药口服溶液剂研发过程中的药学技术要求,2024年7月8日,国家药品监督管理局药品审评中心发布了《化学药品仿制药口服溶液剂药学研究技术指导原则》。本文结合该指导原则的起草背景与过程,对指导原则内容及重点问题进行详细解读,以利于相关研发人员更好的理解和运用。 |
| 关键词: 仿制药 口服溶液剂 指导原则 解读 |
| DOI:10.13506/j.cnki.jpr.2025.06.010 |
| 基金项目: |
|
Publication Date:June 25, 2025
|
|
| Interpretation of “Guideline for Pharmaceutical Research of Chemical Generic Drug Oral Solutions” |
| WANG Gongfu1 |
| (1.Center for Drug Evaluation, National Medical Products Administration, Beijing 100076, China; 2.Greater Bay Area Center for Drug Evaluation and Inspection of National Medical Products Administration, Shenzhen 518000, China) |
| Abstract: |
| Oral solutions have the characteristics of uniform dose distribution, flexible dosage administration, and good patient compliance, and has been paid more attention in the field of domestic drug development in recent years. In order to promote the development of domestic generic drugs and clarify the pharmaceutical technical requirements in the research and development process of chemical generic drug oral solutions, the Center for Drug Evaluation of National Medical Products Administration officially issued the "Guideline for Pharmaceutical Research of Chemical Generic Drug Oral Solutions" on July 8, 2024. This article provides a detailed interpretation, combined the drafting process of the guideline, in order to facilitate better understanding and application by related researchers. |
| Key words: Generic drug Oral solutions Guideline Interpretation |